Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 2
1996 1
1998 1
2002 1
2003 1
2004 3
2005 2
2008 1
2009 1
2010 2
2011 2
2012 1
2013 3
2014 3
2015 1
2016 3
2021 1
2022 3
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Kulasekararaj AG, Griffin M, Langemeijer S, Usuki K, Kulagin A, Ogawa M, Yu J, Mujeebuddin A, Nishimura JI, Lee JW, Peffault de Latour R; 301/302 Study Group. Kulasekararaj AG, et al. Eur J Haematol. 2022 Sep;109(3):205-214. doi: 10.1111/ejh.13783. Epub 2022 Jun 16. Eur J Haematol. 2022. PMID: 35502600 Free PMC article. Clinical Trial.
Genome Instability in Multiple Myeloma: Facts and Factors.
Aksenova AY, Zhuk AS, Lada AG, Zotova IV, Stepchenkova EI, Kostroma II, Gritsaev SV, Pavlov YI. Aksenova AY, et al. Among authors: gritsaev sv. Cancers (Basel). 2021 Nov 26;13(23):5949. doi: 10.3390/cancers13235949. Cancers (Basel). 2021. PMID: 34885058 Free PMC article. Review.
Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment.
Enukashvily NI, Semenova N, Chubar AV, Ostromyshenskii DI, Gushcha EA, Gritsaev S, Bessmeltsev SS, Rugal VI, Prikhodko EM, Kostroma I, Zherniakova A, Kotova AV, Belik LA, Shumeev A, Maslennikova II, Ivolgin DI. Enukashvily NI, et al. Among authors: gritsaev s. Int J Mol Sci. 2022 Mar 20;23(6):3359. doi: 10.3390/ijms23063359. Int J Mol Sci. 2022. PMID: 35328779 Free PMC article.
[The specific features of diagnosis of mixed-phenotype acute leukemia: A combination of B-cell antigen expressions according to the results of flow cytometry and morphological markers of myeloid differentiation in blast cells: A clinical case].
Gritsaev SV, Kostroma II, Ryadnova GM, Tiranova SA, Chubukina ZV, Balashova VA, Zenina MN, Martynkevich IS, Potikhonova NA, Abdulkadyrov KM. Gritsaev SV, et al. Ter Arkh. 2015;87(7):97-100. doi: 10.17116/terarkh201587797-100. Ter Arkh. 2015. PMID: 26390732 Review. Russian.
[Anticytosine therapy for primary myelodysplastic syndrome].
Abdulkadyrov KM, Gritsaev SV, Bessmel'tsev SS, Martynkevich IS, Tiranova SA, Blinov MN, Osipova RI. Abdulkadyrov KM, et al. Among authors: gritsaev sv. Vopr Onkol. 2003;49(4):464-6. Vopr Onkol. 2003. PMID: 14569938 Clinical Trial. Russian.
37 results